Rockin’ on at Clinton/Galva, and start-up delays in Moema. Which storyline is for you? It was the best of times, it was the worst of times, depnding on which analyst you follow. With price targets ranging from $4 to $18 — and warnings from one end over delays at Moema, compared to happy celebration of … Continue reading A Tale of two Solazymes: SZYM reports for Q1 and the analysts offer cheers, jeers